HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

NCT04131413 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Human Papillomavirus Type 16
Cervical Intraepithelial Neoplasia Grade II
Cervical Intraepithelial Neoplasia, Grade III

Interventions

DRUG: pNGVL4aCRTE6E7L2

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]